Cipla Limited (NSE:CIPLA)
1,385.00
-9.70 (-0.70%)
Sep 4, 2026, 3:15 PM IST
Cipla Employees
Cipla had 31,369 employees as of March 31, 2026. The number of employees increased by 1,056 or 3.48% compared to the previous year.
Employees
31,369
Change (1Y)
1,056
Growth (1Y)
3.48%
Revenue / Employee
8.95M INR
Profits / Employee
1.07M INR
Market Cap
1.12T
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 31,369 | 1,056 | 3.48% |
| Mar 31, 2025 | 30,313 | 2,549 | 9.18% |
| Mar 31, 2024 | 27,764 | -4,559 | -14.10% |
| Mar 31, 2023 | 32,323 | 6,396 | 24.67% |
| Mar 31, 2022 | 25,927 | 255 | 0.99% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Zydus Lifesciences | 29,980 |
| Aurobindo Pharma | 29,209 |
| Mankind Pharma | 20,451 |
| Alkem Laboratories | 19,346 |
| Ipca Laboratories | 17,210 |
| Glenmark Pharmaceuticals | 16,946 |
| Divi's Laboratories | 11,565 |
| Ajanta Pharma | 10,421 |
Cipla News
- 1 day ago - India's Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilar - Reuters
- 5 days ago - ‘You’re going overboard’: Bombay high court to FDA, restores Cipla’s licence - The Times of India
- 6 days ago - After Bombay HC rap, FDA withdraws orders against Cipla, MCA eateries - The Times of India
- 7 days ago - Maharashtra FDA cancels Cipla unit’s drug sale licences in Pune - The Times of India
- 7 days ago - Maharashtra FDA cancels Pune Cipla facility’s sale licences over ‘lapses’ - The Times of India
- 7 days ago - Misbranding, storage lapses: FDA cancels Cipla Pune unit’s drug licence over Reactin Plus violations - The Times of India
- 5 weeks ago - Weekly Buzz:CIPLA, VTRS Win FDA Nod; BSX Cuts Jobs; ARGX Snaps Up FBRX; JNJ, GSK Strike Deals - Nasdaq
- 5 weeks ago - Cipla Receives FDA Approval For Generic Advair Diskus In All Strengths - Nasdaq